Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

Find out how nanotechnology can overcome challenges in drug delivery to the eye.

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

As the fires of the American opioid crisis continue to burn, can new painkillers step in?

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.